-
EP2526934
European procedure
Extract from the Register of European Patents
EP About this file: EP2526934
| EP2526934 - Inhibitors of bruton's tyrosine kinase [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.10.2016 Database last updated on 02.11.2024 | Most recent event Tooltip | 14.10.2016 | No opposition filed within time limit | published on 16.11.2016 [2016/46] | Applicant(s) | For all designated states Pharmacyclics LLC 995 East Arques Avenue Sunnyvale, CA 94085 / US | [2015/47] |
| Former [2015/44] | For all designated states Pharmacyclics LLC c/o AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064-6400 / US | ||
| Former [2015/22] | For all designated states Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale, CA 94085 / US | ||
| Former [2012/48] | For all designated states Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale, CA 94086 / US | Inventor(s) | 01 /
Honingberg, Lee 965 Esmerala Ave San Fransisco, CA 94110 / US | 02 /
Verner, Erik 1712 Peck Ave San Mateo, CA 94401 / US | 03 /
Pan, Zhengying 2105 Cypress Ct. Alpharetta, GA 30005 / US | 04 /
Mody, Tarak 955 La Mesa Terrace E Sunnyvale, CA 94086 / US | [2015/46] |
| Former [2012/48] | 01 /
Honingberg, Lee 965 Esmerala Ave San Fransisco, CA 94110 / US | ||
| 02 /
Vernier, Erik 1712 Peck Ave San Mateo, CA 94401 / US | |||
| 03 /
Pan, Zhengying 2105 Cypress Ct. Alpharetta, GA 30005 / US | |||
| 04 /
Mody, Tarak 955 La Mesa Terrace E Sunnyvale, CA 94086 / US | Representative(s) | Cole, William Gwyn, et al Avidity IP Broers Building Hauser Forum 21 J J Thomson Avenue Cambridge CB3 0FA / GB | [N/P] |
| Former [2015/50] | Wilkinson, Marc George, et al Avidity IP Broers Building Hauser Forum 21 JJ Thomson Ave Cambridge CB3 0FA / GB | ||
| Former [2012/48] | Wilkinson, Marc George, et al avidity IP Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB | Application number, filing date | 12166305.8 | 28.12.2006 | [2012/48] | Priority number, date | US20060826720P | 22.09.2006 Original published format: US 826720 P | US20060828590P | 06.10.2006 Original published format: US 828590 P | [2012/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2526934 | Date: | 28.11.2012 | Language: | EN | [2012/48] | Type: | A3 Search report | No.: | EP2526934 | Date: | 05.12.2012 | [2012/49] | Type: | B1 Patent specification | No.: | EP2526934 | Date: | 09.12.2015 | Language: | EN | [2015/50] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.11.2012 | Classification | IPC: | A61K31/00, A61K31/519, A61K45/06, C07D487/04, A61P35/02 | [2015/23] | CPC: |
A61K31/52 (EP,US);
C07D487/04 (EP,KR,US);
A61K31/00 (EP,US);
A61K31/519 (EP,KR,US);
A61K39/3955 (US);
A61K45/06 (EP,US);
A61K9/4825 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/00 (EP);
A61P13/02 (EP);
A61P13/08 (EP);
A61P13/10 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P15/02 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P17/14 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/02 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P5/14 (EP);
A61P7/02 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
C07D401/04 (KR);
C07K16/2887 (US);
A61K2300/00 (US);
C07K2317/24 (US)
(-)
| C-Set: |
A61K31/519, A61K2300/00 (EP,US)
|
| Former IPC [2012/49] | A61K31/00, A61K31/519, A61P35/02, C07D487/04 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2015/50] |
| Former [2012/48] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Hemmer der Bruton-Tyrosinkinase | [2012/48] | English: | Inhibitors of bruton's tyrosine kinase | [2012/48] | French: | Inhibiteurs de la tyrosine kinase de bruton | [2012/48] | Examination procedure | 05.06.2013 | Examination requested [2013/29] | 17.09.2013 | Amendment by applicant (claims and/or description) | 03.12.2013 | Despatch of a communication from the examining division (Time limit: M06) | 10.07.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 17.09.2014 | Reply to a communication from the examining division | 29.05.2015 | Communication of intention to grant the patent | 02.10.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 02.10.2015 | Fee for grant paid | 02.10.2015 | Fee for publishing/printing paid | 16.10.2015 | Information about intention to grant a patent | 16.10.2015 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP06850039.6 / EP2081435 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060850039) is 21.04.2010 | Opposition(s) | 12.09.2016 | No opposition filed within time limit [2016/46] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 17.09.2014 | Request for further processing filed | 17.09.2014 | Full payment received (date of receipt of payment) Request granted | 01.10.2014 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 17.09.2013 | Request for further processing filed | 17.09.2013 | Full payment received (date of receipt of payment) Request granted | 07.10.2013 | Decision despatched | Fees paid | Renewal fee | 31.08.2012 | Renewal fee patent year 03 | 31.08.2012 | Renewal fee patent year 04 | 31.08.2012 | Renewal fee patent year 05 | 25.05.2012 | Renewal fee patent year 06 | 26.12.2012 | Renewal fee patent year 07 | 12.12.2013 | Renewal fee patent year 08 | 11.12.2014 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2016/36] |
| Former [2016/27] | BE | 31.12.2015 | |
| Former [2016/25] | LV | 09.12.2015 | |
| BE | 31.12.2015 | ||
| Former [2016/24] | BE | 31.12.2015 | Documents cited: | Search | [A]WO9954286 (WAYNE HUGHES INST [US]); | [A]US2004006083 (HIRST GAVIN C [US], et al); | [E]WO2007136790 (MANNKIND CORP [US], et al) | by applicant | US3598122 | US3598123 | US3710795 | US3731683 | US3742951 | US3814097 | US3921636 | US3972995 | US3993072 | US3993073 | US3996934 | US4031894 | US4060084 | US4069307 | US4077407 | US4151273 | US4201211 | US4229447 | US4230105 | US4292299 | US4292303 | US4327725 | US4343789 | US4476116 | US4596795 | US4624848 | US4755386 | US4871549 | US4968509 | US5011692 | US5017381 | US5033252 | US5052558 | US5116817 | US5229135 | US5260068 | US5260069 | US5281420 | US5323907 | US5336168 | US5340591 | US5456923 | US5461140 | US5508040 | US5516527 | US5567441 | US5622721 | US5665378 | US5686105 | US5700485 | US5700410 | US5723269 | US5739136 | US5837284 | US5837280 | US5840329 | US5858401 | US5869090 | US5977175 | US6083518 | WO0119829 | US6326469 | US6391452 | US6465014 | US6667048 | US2004013734 | US6923983 | US6929801 | US6932983 | US6946144 | US6960563 |